Covid-19 Neurology News

Loss of sense of smell and taste may last up to 5 months after COVID-19

17 Feb 2021

People with COVID-19 may lose their sense of smell and taste for up to five months after infection, according to a preliminary study released today, February 22, 2021, that will be presented at the American Academy of Neurology's 73rd Annual Meeting.

A plea for equitable global access to COVID‐19 diagnostics, vaccination and therapy: the NeuroCOVID‐19 task Force of the EAN

18 Jan 2021

COVID‐19 continues to challenge health and care systems around the globe. The pandemic has disrupted acute neurology services and routine patient care and has impacted the clinical course in patients with chronic neurologic disease. COVID‐19 appears to have exposed inequalities of societies and healthcare systems and had disproportionate impact on already vulnerable communities. 

NIH study uncovers blood vessel damage and inflammation in COVID-19 patients’ brains but no infection

30 Dec 2020

Results from a study of 19 deceased patients suggests brain damage is a byproduct of a patient’s illness.

No association between COVID-19 and Guillain-Barré syndrome

13 Dec 2020

Neuroscientists at UCL have found no significant association between COVID-19 and the potentially paralysing and sometimes fatal neurological condition Guillain-Barré syndrome. Researchers say the findings, published in the journal Brain, along with a linked scientific commentary by UCL and other international experts, should provide the public with reassurance, as the UK’s national coronavirus vaccination programme is rolled out.

How SARS-CoV-2 reaches the brain

30 Nov 2020

Using post-mortem tissue samples, researchers from Charité – Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19. For the first time, researchers have been able to produce electron microscope images of intact coronavirus particles inside the olfactory mucosa.

Neurology of COVID 19 - Session 5 of Neuroinfection Series 2 on Sat. 7 Nov

4 Nov 2020

The 5th session of the Tropical and Geographical Specialty Group (TGNSG) of the World Federation of Neurology Neuroinfection Series 2 is on Neurology of COVID 19 on Sat 7 November.

What EEGs tell us about COVID-19 and the brain

26 Oct 2020

Researchers from Baylor College of Medicine and the University of Pittsburgh have gathered more than 80 studies, reviewed the data, and identified commonalities that are helping to paint a broader picture of how COVID-19 affects the brain.

EAN consensus statement for management of patients with neurological diseases during the COVID‐19 pandemic

15 Oct 2020

The recent SARS‐CoV‐2 pandemic has posed multiple challenges to the practice of clinical neurology including recognition of emerging neurological complications and management of coexistent neurological diseases. In a fast‐evolving pandemic, evidence‐based studies are lacking in many areas. This paper presents European Academy of Neurology (EAN) expert consensus statements to guide neurologists caring for patients with COVID‐19.

Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community

13 Oct 2020

Professor Tissa Wijeratne and Professor Sheila Crewther published the first research paper introducing the Post Covid-19 Neurological Syndrome(PCNS) in Journal of the Neurological Sciences today.

Nearly one-third of COVID-19 patients in study had altered mental state

10 Oct 2020

Nearly a third of hospitalized COVID-19 patients experienced some type of altered mental function — ranging from confusion to delirium to unresponsiveness — in the largest study to date of neurological symptoms among coronavirus patients in a U.S. hospital system.
1 3